Invenomic Capital Management’s Kohl's KSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-475,299
Closed -$4.03M 161
2025
Q2
$4.03M Sell
475,299
-605,137
-56% -$4.65M 0.23% 111
2025
Q1
$8.84M Buy
1,080,436
+41,676
+4% +$484K 0.45% 81
2024
Q4
$14.6M Buy
1,038,760
+4,848
+0.5% +$83.5K 0.69% 43
2024
Q3
$21.8M Buy
1,033,912
+139,519
+16% +$2.84M 1.2% 29
2024
Q2
$20.6M Buy
894,393
+738,688
+474% +$17.8M 1% 33
2024
Q1
$4.54M Sell
155,705
-261,044
-63% -$7M 0.24% 96
2023
Q4
$12M Buy
+416,749
New +$9.77M 0.55% 65
2021
Q1
Sell
-7,279
Closed -$296K 139
2020
Q4
$296K Sell
7,279
-42,718
-85% -$1.24M 0.08% 117
2020
Q3
$927K Buy
49,997
+23,861
+91% +$505K 0.51% 65
2020
Q2
$543K Buy
+26,136
New +$504K 0.4% 77

Other funds holding KSS

Invenomic Capital Management's KSS Position: Q3 2025 in Review

Invenomic Capital Management sold out of Kohl's (KSS) in Q3 2025, closing a stake of 475,299 shares — an estimated $4.03M sold.

Invenomic Capital Management first reported a position in KSS in Q2 2020 and held it in 10 quarters. The position peaked at $21.8M in Q3 2024. 338 funds tracked by Wall St. Rank hold KSS as of Q3 2025.

  • Invenomic Capital Management reported no remaining Kohl's position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 475,299 Kohl's shares in Q3 2025, an estimated $4.03M.
  • Invenomic Capital Management first reported a position in Kohl's in Q2 2020 and held it in 10 quarters.
  • Invenomic Capital Management's Kohl's position peaked at $21.8M in Q3 2024.
  • 338 funds tracked by Wall St. Rank held Kohl's as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.